• Phone+46462220758
  • Visiting address

    Skånes universitetssjukhus

    Lund

    Sweden

  • Postal address

    22184

    Sweden

Unit profile

Research

This project aims to develop incretin therapy as a glucose-reducing strategy in type 2 diabetes (T2D). Its particular focus is to understand the mechanisms of incretin therapy and to optimize its clinical positioning. This mission is achieved by an interdisciplinary approach with complementary studies in subjects with T2D, healthy volunteers and experimental animals.

UKÄ subject classification

  • Endocrinology and Diabetes

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • Diabetes

    Medicine, Lund

    Organisational unit: Research group